- Tytuł:
- Intravitreous treatment of severe ocular von Hippel–Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trial.
- Autorzy:
- Źródło:
- Clinical & Experimental Ophthalmology. Dec2021, Vol. 49 Issue 9, p1048-1059. 12p.
Czasopismo naukowe